Ian Kimber

University of British Columbia — Canada

Medicine · Health Sciences

76h-index19.5kcitations459works2.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Contact Dermatitis and Allergies(244), Allergic Rhinitis and Sensitization(116), Occupational exposure and asthma(93), Immunotoxicology and immune responses(72), Animal testing and alternatives(69)

Publications459 total

Food for thought: probiotic modulation of microglial activity in Parkinson's disease
Frontiers in Molecular Neuroscience·2025· 1 citedOpen Access
An extended Reference Chemical Potency List (RCPL) for characterising the performance of New Approach Methodologies (NAMs) in measuring the skin sensitisation potency of fragrance chemicals
Regulatory Toxicology and Pharmacology·2025· 2 citedOpen Access
OS02-09 Skin sensitization potency assessment of fragrance chemicals for quantitative risk assessment – comparing in vivopotency values to the point-of-departure derived with new approach methodologies
Toxicology Letters·2025
Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article
Human Gene Therapy·2024· 6 citedOpen Access
Specificity of the local lymph node assay (LLNA) for skin sensitisation
Regulatory Toxicology and Pharmacology·2023· 7 citedOpen Access
Reference Chemical Potency List (RCPL): A new tool for evaluating the accuracy of skin sensitisation potency measurements by New Approach Methodologies (NAMs)
Regulatory Toxicology and Pharmacology·2022· 14 citedOpen Access
Enzymes and sensitization via skin exposure: A critical analysis
Regulatory Toxicology and Pharmacology·2021· 8 citedOpen Access
Determination of the relative allergenic potency of proteins: hurdles and opportunities
Critical Reviews in Toxicology·2020· 14 cited
A response to Professor Steinemann
Regulatory Toxicology and Pharmacology·2019
Characterization of Epidermal Langerhans Cells
2019
The Local Lymph Node Assay
2019
Proteomics and AllerCatPro analysis for the identification of low allergenic proteins
Toxicology Letters·2018
Langerhans cells express human β-defensin 3: relevance for immunity during skin ageing
British Journal of Dermatology·2018· 17 citedOpen Access
The future trajectory of adverse outcome pathways: a commentary
Archives of Toxicology·2018· 32 citedOpen Access
Impaired Langerhans cell migration in psoriasis is due to an altered keratinocyte phenotype induced by interleukin-17
British Journal of Dermatology·2017· 39 citedOpen Access
Contact Hypersensitivity
Elsevier eBooks·2017· 2 cited
Azodicarbonamide (ADCA): A reconsideration of classification as a respiratory sensitiser
Regulatory Toxicology and Pharmacology·2017· 19 citedOpen Access
Data on the histological and immune cell response in the popliteal lymph node in mice following exposure to metal particles and ions
Data in Brief·2016· 1 citedOpen Access
331 Addition of interleukin-17 alters the healthy keratinocyte secretome and causes inhibition of Langerhans’ cell migration
Journal of Investigative Dermatology·2016
Setting Occupational Exposure Limits for Chemical Allergens—Understanding the Challenges
Journal of Occupational and Environmental Hygiene·2015· 35 citedOpen Access
page 1 of 23Next →

Frequent Co-authors

Rebecca J. Dearman(27), David A. Basketter(22), G. Frank Gerberick(10), Marie Cumberbatch(9), Cindy A. Ryan(6), E.W. Scholes(5), Petra Kern(4), Frank Gerberick(4), C. A. Ryan(4), Jennifer Hilton(4), Aynur O. Aptula(3), C.E.M. Griffiths(3), Grace Patlewicz(2), Klaus E. Andersen(2), Silvia Casati(2), Henk Van Loveren(2), C. Weisenberger(2), Linda J. Lea(2), Andrea Dickens(2), Ian Pate(2)